The Christopher Reeve Paralysis Foundation (CRPF) has just awarded Dr. Mike Fainzilber, a neuroscientist at the Weizmann Institute, a two-year grant of $149,600 in research funds. The grant represents the first time CRPF has funded spinal cord injury research in Israel. The Israel21c website noted that only 15 outstanding neuroscientists worldwide were awarded funding in CRPF's first grant cycle of 2004.
"CRPF has proudly supported the work of many of the most accomplished neuroscientists in the world," said Christopher Reeve, CRPF's Chairman of the Board and a theater and film actor who is himself paralyzed. "The Weizmann Institute, as I saw first-hand when I visited Israel last year," he continued, "has established preeminence in the field of paralysis research."
Dr. Fainzilber's research is aimed at developing a method to modulate the nervous system changes induced by traumatic injury. The ability to identify and manipulate the peptides in this process will hopefully facilitate clinical approaches that will enhance regeneration in patients with nerve injuries.
Israel21c quoted Dr. Fainzilber as commenting, "CRPF support is crucial to us for two reasons, firstly because without this financial support we simply would not be able to carry out the project, and secondly because it is very encouraging to know that we have the attention and, hopefully, future input and support from some of the best people in the field of nerve regeneration."
"CRPF has proudly supported the work of many of the most accomplished neuroscientists in the world," said Christopher Reeve, CRPF's Chairman of the Board and a theater and film actor who is himself paralyzed. "The Weizmann Institute, as I saw first-hand when I visited Israel last year," he continued, "has established preeminence in the field of paralysis research."
Dr. Fainzilber's research is aimed at developing a method to modulate the nervous system changes induced by traumatic injury. The ability to identify and manipulate the peptides in this process will hopefully facilitate clinical approaches that will enhance regeneration in patients with nerve injuries.
Israel21c quoted Dr. Fainzilber as commenting, "CRPF support is crucial to us for two reasons, firstly because without this financial support we simply would not be able to carry out the project, and secondly because it is very encouraging to know that we have the attention and, hopefully, future input and support from some of the best people in the field of nerve regeneration."